AeroLeads people directory · profile
Dushyant Pathak Email & Phone Number
Interim Chief Executive Officer
at
Autobahn Labs, Inc.
2 work emails found
@ventureedge.net
LinkedIn matched
✓ Verified May 2026
4 data sources
Profile completeness 100%
Current company
Role
Interim Chief Executive Officer
Location
San Francisco, California, United States
Company size
Who is Dushyant Pathak? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Dushyant Pathak is listed as Interim Chief Executive Officer at Autobahn Labs, Inc., a company with 7 employees, based in San Francisco, California, United States. AeroLeads shows a work email signal at ventureedge.net and a matched LinkedIn profile for Dushyant Pathak.
Dushyant Pathak previously worked as Strategic & Translational Advisor at Sierra Biopharma, Inc. and Executive Chairman at Sierra Biopharma, Inc.. Dushyant Pathak holds Mba, Management Of Technology; Entrepreneurship from University Of California, Berkeley, Haas School Of Business.
Company email context
Email format at Autobahn Labs, Inc.
This section adds company-level context without repeating Dushyant Pathak's masked contact details.
{first}@ventureedge.net
89% confidence
AeroLeads found 2 current-domain work email signals for Dushyant Pathak. Compare company email patterns before reaching out.
Profile bio
About Dushyant Pathak
As the founder and managing member of VentureEdge LLC, I deliver financing, business development and operational solutions within a strategic framework customized to emerging companies' and early-stage investors’ business needs and capital formation goals. My business leadership roles have included being an SEC-reporting, section 16 officer with experience in Fortune-500, early-stage and start-up companies in roles as CEO, leading business development, and directing non-clinical and clinical project operations and pharmaceutical product development. I have been an active member of leadership teams responsible for transformative M&A transactions and a successful NASDAQ IPO, including actively participating in raising over $100 million in investment capital over my career. As an investor, I worked in venture capital with Connecticut Innovations and as the first Entrepreneur-in-Residence at Mission Bay Capital. At UC Davis, as its first associate vice chancellor focused on innovation and technology commercialization, I led corporate engagement, IP management and startup support functions. I developed and led comprehensive, cross-disciplinary technology commercialization and regional economic engagement, instrumental in translating cutting-edge academic research into technology-enabled economic impact in the Sacramento region, which included launching a network of local and regional incubators. My academic research and teaching experience includes being on the research faculty at Yale University in molecular biophysics and biochemistry, and a visiting professor of entrepreneurship at UC Berkeley’s Haas School of Business. At the University of San Francisco, I have a graduate-level focus on entrepreneurship and technology management. Consistent with my belief in the global relevance of US experience in translating research into social impact, I have actively engaged in international educational engagements. In addition to private-company boards, I have provided guidance on a number of not-for-profit boards, including the Sacramento Area Regional Technology Alliance, the California Technology Council, and the Leadership and Small Business Technology Councils of the National Small Business Association. As a member of the Commission on Innovation, Competitiveness and Economic Prosperity (CICEP) of the Association of Public and Land Grant Universities (APLU), I served on the CICEP’s Executive Committee and its Strategic Communications sub-committee, and co-chaired its Innovation and Economic Competitiveness (IEP) Designation sub-committee.
Listed skills include Leadership, Research And Development, Strategic Partnerships, Cell Biology, and 46 others.
Current workplace
Dushyant Pathak's current company
Company context helps verify the profile and gives searchers a useful next step.
Autobahn Labs, Inc.
41 roles · 18 years
Dushyant Pathak work experience
A career timeline built from the work history available for this profile.
Strategic & Translational Advisor
Current
Sierra Biopharma, Inc.
Dec 2024 - Present
Executive Chairman
Sierra Biopharma, Inc.
Feb 2023 - Dec 2024
Member Board Of Directors
Sierra Biopharma, Inc.
Aug 2021 - Dec 2024
Acting Chief Executive Officer
Sierra Biopharma, Inc.
Sierra Biopharma is taking a new approach to treat myasthenia gravis with an antigen-specific therapy that attacks the cause of the disease without suppressing the immune system. To accomplish this, the company is developing a targeted biologic molecule that not only binds to, neutralizes and clears pathogenic antibodies, but also binds to and eliminates.
Sep 2021 - Feb 2023
Founder & Managing Member
CurrentVentureEdge LLC specializes in delivering financing, business development and operational solutions within a strategic framework customized to emerging companies' business needs and capital formation challenges. Navigating successfully within a competitive environment, with constrained resources, requires experience gained from raising capital and growing.
Aug 2008 - Present
President, Ceo & Head Of Operations
Current
Feb 2024 - Present
President & Chief Operating Officer
Apr 2023 - Feb 2024
Acting Chief Operating Officer / Head Of Non-Clinical Development Operations
FGH BioTech, Inc., a drug discovery and development company, specializes in the development of drugs for the treatment of metabolic disorders, including cancers whose progression and maintenance is driven by metabolic dysregulation of lipogenesis. Its small molecule drug candidates target the master metabolic switch regulating homeostasis between lipid.
Apr 2020 - Mar 2023
Transactions And Alliances
CurrentAutobahn Labs is a virtual incubator for early-stage drug discovery and development, partnering with leading research institutions to accelerate the advancement of novel science to deliver transformational new therapies for patients. The organization invests intellectual, financial and physical capital, applying a proven drug discovery framework to.
Mar 2020 - Present
Acting Chief Executive Officer
Current
Nuclear Rna Networks, Inc.
The company is applying its proprietary technology and know-how relating to small non-coding RNA, for the discovery and development of novel therapeutics to treat important disease indications including cancer.
Feb 2023 - Present
Member Board Of Directors
Current
Nuclear Rna Networks, Inc.
Feb 2023 - Present
Independent Board Director
Current
Furanica, Inc.
Furanica is an early-stage, small molecule drug discovery company developing a proprietary pipeline of drug candidates for the treatment of hypertriglyceridemia, a condition affecting over 3 million Americans and often associated with cardiovascular diseases and type 2 diabetes. The company is leveraging its proprietary research on the direct role of furan.
Oct 2022 - Present
Adjunct Professor, School Of Management
CurrentUSF's School of Management is located in the heart of San Francisco, one of the most intense business ecosystems in the world, which allows the School and its faculty to provide students with unparalleled access to high tech, biotech, finance, venture capital, and entrepreneurial leaders.
May 2021 - Present
Member Dean'S Circle Advisory Board
CurrentThe Dean's Circle provides a sounding board for the Dean, connection to local businesses, and assessment of key issues. This group has invested in and suggested projects such as marketing and branding, faculty support, facility improvement, student activities and building a strong culture in the School.
Feb 2023 - Present
Network Expert
CurrentGLG is a worldwide network of knowledge experts. GLG's clients rely on GLG’s global team to connect with powerful insight across fields from its network of approximately 1 million experts. GLG serves thousands of the world’s best businesses, from Fortune 500 corporations to leading technology companies to professional services firms and financial.
Oct 2012 - Present
Berkeley Haas Lsbe / Lsec Expert Council Member
CurrentThe Berkeley Haas Life Sciences Business and Entrepreneurship (LSBE) Program is designed to help students bridge scientific inquiry and research with entrepreneurship and commercial application. The Life Sciences Entrepreneurship Center (LSEC) fosters the creation of innovative and transformative life sciences companies for the betterment of society and.
Feb 2022 - Present
Nov 2022 - Nov 2024
President, San Francisco Bay Area Chapter
Volunteer Position. The Private Directors Association®, an independent 501(c)(6), is the only national association dedicated to improving private companies' growth and sustainability through effective board governance. With more than 3,000 members, the association represents a diverse and highly experienced community of executive leaders, including current.
May 2021 - Nov 2022
San Francisco Bay Area Chapter Founder & Founding Chair, Programs Committee
The San Francisco Bay Area Chapter was founded in 2020
Jul 2020 - May 2021
Member Board Of Directors
Multiplexthera, Inc.
Jul 2020 - Oct 2023
President & Chief Executive Officer / Co-Founder
Multiplexthera, Inc.
MultiplexThera is advancing a proprietary, synthetic-biology and computationally-driven, Disease Antigen Specific High-throughput Drug Discovery platform that accelerates the discovery and optimization of safer and more effective, pHLA-targeted therapeutics. This game-changing proprietary platform enables the discovery of drugs that are de novo designed.
Jul 2020 - Oct 2023
Nsba Leadership Council; Technology Council
Volunteer Position. With more than 80 years representing America’s small-business owners, NSBA is a nonpartisan organization with 65,000 members in every state and every industry in the U.S. It is the nation’s first small-business advocacy organization.
Dec 2020 - Jan 2022
Pipeline Strategy Consultant, Business Development & Competitive Strategy
NextCure is a clinical-stage biopharmaceutical company focused on discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function.
Apr 2020 - Sep 2020
Senior Vice President Business Development
Sep 2019 - Apr 2020
Associate Vice Chancellor Of Research, Innovation & Technology Commercialization
May 2019 - Sep 2019
Founder & Executive Director, Venture Catalyst
Startup support and resources for technology innovators and entrepreneurs
Jun 2013 - Sep 2019
Associate Vice Chancellor Of Research, Technology Management & Corporate Relations
Enabling the efficient translation of UC Davis technology into effective industry engagements and the creation of startups and new ventures based on the university's intellectual assets.
Jan 2012 - May 2019
Board Director
Apr 2012 - Aug 2016
Adjunct Professor
Executive MBA program: Entrepreneurial Management & New Venture Finance
2008 - 2015
~7 yrs
Entrepreneur In Residence
First EIR at Mission Bay Capital's first venture capital fund. Focus on life science startups originating from of affiliated with the University of California and QB3.
2010 - 2012
~2 yrs
Vice President, Business Development
Izumi Bio / Ipierian
Induced pluripotent stem cells for drug discovery and development. Acquired by BMS.
2009 - 2010
~1 yr
President And Ceo
Cellexicon
Molecular Diagnostics Startup. Executed unique “Reverse Licensing” transaction with NYU.
Dec 2007 - Jan 2009
Vice President, Program Management & Corporate Development
Biopharmaceutical discovery and development focused on ischemic stroke, neurological disorders and pain. Responsible for business development and non-clinical and clinical project operations involving successful IND filing through multi-center phase 2 clinical trials with multiple small-molecule drug candidates. Section 16 SEC-reporting officer - NASDAQ.
Dec 2002 - Dec 2006
Senior Vice President, Corporate Development & Strategic Planning
Centaur Pharmaceuticals
Small molecule drug discovery and development company merged into Renovis. Responsible for all elements of business strategy, capital formation, transactions and M&A.
Jan 2001 - Dec 2002
President & Ceo, Board Director
Bioprotocol
Startup focused on data, information services and eCommerce enablement for pharmaceutical and biotech company researchers. Acquired by BioOnline.
Jan 2000 - Dec 2000
Senior Director, Corporate Development / Director, Business Development
Axys Pharmaceuticals / Arris Pharmaceutical Corporation
Publicly-traded small molecule drug discovery company. Acquired by Celera.
Apr 1997 - Jan 2000
Business Development Analyst
Fortune 500 Biopharmaceutical company. Acquired by Novartis.
Jun 1996 - Apr 1997
Investment Associate
Venture Capital company focused on investing funds from the State of Connecticut's long-term bonds in Connecticut-based technology driven startups and early stage companies. Performed diligence resulting in early investments in Alexion and Curagen.
Sep 1994 - Aug 1995
Research Faculty
Molecular Biophysics & Biochemistry DepartmentRNA Structural Biology
Aug 1993 - Aug 1994
Post-Doctoral Fellow
Damon Runyon - Walter Winchell Cancer Fund FellowStructural Biology Researcher - Protein / Nucleic Acid InteractionsMolecular Biophysics & Biochemistry Department
Sep 1989 - Aug 1993
6 education records
Dushyant Pathak education
Mba, Management Of Technology; Entrepreneurship
University Of California, Berkeley, Haas School Of Business
Ph.D., Biochemistry, Molecular Biology & Cell Biology; Protein X-Ray Crystallography / Structural Biology
Northwestern University
Bachelor Of Arts, Natural Science & Mathematics
Bennington College
Education record
Birla Institute Of Technology And Science, Pilani
Education record
St. Xavier'S College
Education record
The Cathedral And John Connon School
FAQ
Frequently asked questions about Dushyant Pathak
Quick answers generated from the profile data available on this page.
What company does Dushyant Pathak work for?
Dushyant Pathak works for Autobahn Labs, Inc..
What is Dushyant Pathak's role at Autobahn Labs, Inc.?
Dushyant Pathak is listed as Interim Chief Executive Officer at Autobahn Labs, Inc..
What is Dushyant Pathak's email address?
AeroLeads has found 2 work email signals at @ventureedge.net for Dushyant Pathak at Autobahn Labs, Inc..
Where is Dushyant Pathak based?
Dushyant Pathak is based in San Francisco, California, United States while working with Autobahn Labs, Inc..
What companies has Dushyant Pathak worked for?
Dushyant Pathak has worked for Autobahn Labs, Inc., Sierra Biopharma, Inc., Ventureedge Llc, Fgh Biotech, Inc., and Nuclear Rna Networks, Inc..
Who are Dushyant Pathak's colleagues at Autobahn Labs, Inc.?
Dushyant Pathak's colleagues at Autobahn Labs, Inc. include Jared Feldman, Phd.
How can I contact Dushyant Pathak?
You can use AeroLeads to view verified contact signals for Dushyant Pathak at Autobahn Labs, Inc., including work email, phone, and LinkedIn data when available.
What schools did Dushyant Pathak attend?
Dushyant Pathak holds Mba, Management Of Technology; Entrepreneurship from University Of California, Berkeley, Haas School Of Business.
What skills is Dushyant Pathak known for?
Dushyant Pathak is listed with skills including Leadership, Research And Development, Strategic Partnerships, Cell Biology, Executive Management, Mergers, Neuroscience, and Genomics.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial